Overview
A delayed hemolytic transfusion reaction (DHTR) occurs when a patient previously sensitized to a red cell antigen, with the antibody undetectable at pretransfusion testing, mounts a rapid anamnestic (secondary) antibody response after re-exposure to that antigen on transfused donor cells, days to weeks after transfusion, with laboratory or clinical evidence of hemolysis. The same antibody appearance without hemolysis evidence is a delayed serologic transfusion reaction (DSTR).
Classification
| Category | Antibody found? | Hemolysis evidence? |
|---|---|---|
| DHTR | Yes, newly detectable alloantibody | Yes, falling hemoglobin, positive DAT/elution, supportive markers |
| DSTR | Yes, newly detectable alloantibody | No, no hemolysis pattern despite the new antibody |
Morphologic Features
Not a cell-morphology topic, this is a delayed-reaction investigation and interpretation reference.
Laboratory Characteristics
- Antibody screen/identification on the current specimen detects a newly appeared alloantibody absent (or undetectable) on the original pretransfusion specimen
- DAT on the current specimen may be positive, often mixed-field, reflecting a mixture of antigen-negative and antigen-positive red cells
- Elution recovers and identifies antibody bound to red cells when DAT is positive, ideally concordant with the antibody screen/ID result
- Hemolysis correlation uses hemoglobin trend, bilirubin, and haptoglobin (where ordered) against the transfusion timeline
Reference Intervals
Not applicable in the quantitative sense, this is a qualitative correlation of antibody findings with the hemolysis trend. Institutional timelines for repeat antibody screening and extended workup triggers are SOP-specific; verify against current protocol.
Clinical and Laboratory Significance
Distinguishing DHTR from DSTR affects how the event is classified and reported, but in both cases the newly identified antibody is permanently documented in the patient's transfusion history, since it typically remains clinically significant going forward and drives antigen-negative unit selection for future transfusions.
Differential Considerations
Distinguish DHTR/DSTR from ABO-incompatible AHTR (immediate onset, intravascular hemolysis, clerical-error association) and from non-transfusion causes of a falling hemoglobin or new jaundice (e.g., ongoing bleeding, other hemolytic processes unrelated to transfusion) before attributing the picture to a delayed alloimmune response.
Comparison Tables
AHTR vs. DHTR/DSTR laboratory contrast
| Feature | ABO-incompatible AHTR | DHTR/DSTR |
|---|---|---|
| Onset | Minutes to hours | Days to ~1–2 weeks |
| Antibody class | Pre-formed IgM | Anamnestic IgG |
| Hemolysis type | Intravascular (complement-mediated) | Usually extravascular (macrophage-mediated) |
| Usual root cause | Clerical/identification error | Antibody undetectable at prior screening |
Classification Frameworks
Not applicable, laboratory reaction-investigation pathway, not a WHO disease classification.
Laboratory Notes
- A new antibody without hemolysis evidence is a DSTR, not a DHTR, don't conflate antibody appearance with confirmed hemolysis
- A mixed-field or weak DAT is common in DHTR and should prompt elution rather than dismissal
- Document any newly identified antibody permanently, regardless of DHTR vs. DSTR classification, for future antigen-negative unit selection
References
Authoritative textbooks, guidelines, and reviews supporting this reference entry. Verify reference intervals, critical limits, and reflex criteria against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
Frequently Asked Questions
Common questions about using this Delayed Hemolytic Transfusion Reaction (DHTR) additional test references Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Delayed Hemolytic Transfusion Reaction (DHTR) laboratory reference?
Delayed Hemolytic Transfusion Reaction (DHTR) is a Additional Test References entry in the LabPedia Medical Laboratory Library, written for Medical Laboratory Science reference lookup.
How should students use this medical laboratory encyclopedia page?
Read the structured sections for quick orientation, then follow related links into Academy lessons or Challenge Center practice when you need teaching or assessment.
Does this page replace laboratory textbooks?
No. It is a concise educational laboratory reference. Use recognized laboratory medicine sources and your institutional procedures for definitive practice decisions.
Where can I find related laboratory tests?
Use related links on this page when present, or browse Laboratory Library discipline catalogues for laboratory tests and interpretation references.
Is this content part of Medical Laboratory Education on LabPedia?
Yes. Library references support Medical Laboratory Education alongside Academy courses, medical laboratory quizzes, and laboratory case studies.
Can reference details vary between laboratories?
Yes. Methods, intervals, and reporting conventions vary. Always confirm details against your laboratory’s current protocols.
How do I return to Library search or categories?
Use breadcrumbs to open the Library hub, discipline catalogues, or other reference collections for continued medical laboratory resource browsing.